FloridaMarijuana.net

JUNE 22, 2018

Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids.

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

APRIL 7, 2022

The study’s researchers, who voiced concern about the current pharmaceutical treatment for MS, looked at the neurological benefits, clinical challenges, and neuropathologic promise of medical cannabis for MS. In a survey of 5,481 MS patients, 47% considered using MMJ, but only 20% spoke with their physician about it.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

FloridaMarijuana.net

JULY 6, 2018

As the rate of cancer diagnoses rises worldwide, patients are finding more options with their treatments and healthcare routines. Patients can suffer from the disease itself, or from the side effects of chemotherapy and other pharmaceuticals medications. This epidemic affects not only patients, but their families and caregivers.

Strains 189

Strains Indica Nerve Pain Hybrid 189

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. The endocannabinoid system consists of cannabinoid receptors all over the body. The compounds THC (tetrahydrocannabinol) and CBD (cannabidiol) found in cannabis signal the same cannabinoid receptors as anandamide.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 83

Pharmaceutical Clinical Trials Therapy Programs 83

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. GW Pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

FloridaMarijuana.net

OCTOBER 5, 2018

Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine. THC and CBD are two popular cannabinoids, and have been used medicinally for centuries. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications.

Terpenes 181

Terpenes Strains Oil Medicine 181

Leafwell

JANUARY 15, 2021

This article is for medical marijuana patients and physicians alike. We believe knowledge is power and Leafwell seeks to educate not only patients but medical professionals as well.

Pharmaceutical 117

Pharmaceutical Education Cannabinoids Patients 117

Leafwell

JANUARY 15, 2021

This article is for medical marijuana patients and physicians alike. We believe knowledge is power and Leafwell seeks to educate not only patients but medical professionals as well.

Pharmaceutical 117

Pharmaceutical Education Cannabinoids Patients 117

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Project CBD

SEPTEMBER 12, 2023

Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals.

Chronic Pain 233

Chronic Pain Treatment Cannabinoids Research and Development 233

FloridaMarijuana.net

AUGUST 9, 2018

Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. This means that often pharmaceutical medications are experimental.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

Greencamp

MAY 1, 2019

Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. However, some people don’t react well to antiemetics—most notably cancer patients going through aggressive chemo. And that’s where cannabis comes into play.

Patients 89

Patients Strains Sativa Marijuana 89

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

FloridaMarijuana.net

AUGUST 15, 2018

Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones. While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Project CBD

FEBRUARY 1, 2023

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains.

Conditions 130

Conditions THC CBD Cannabinoids 130

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

United Patients Group

FEBRUARY 7, 2023

The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Cannabis Law Report

JANUARY 3, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Despite the recently announced national lockdown in the Netherlands, our CRO is continuing to screen and enroll patients,” stated Daniel Schneeberger, M.D., There is a large and growing need to treat acute cannabinoid intoxication with 1.7

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Factors such as diet and stress are known to aggravate IBD patients, but they do not cause it. . What is IBS? What is the Difference Between IBD and IBS?

Digestion 124

Digestion Treatment Conditions Research and Development 124

FloridaMarijuana.net

OCTOBER 11, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. As researchers dive into the depths of the cannabinoid system it is becoming clear that cannabis terpenes are just as vital to a plant’s efficacy as are THC and CBD.

Terpenes 172

Terpenes Strains Medicine Oil 172

The Cannigma

JUNE 2, 2022

Ever wondered how cannabinoids like THC or CBD affect your blood? It turns out that this issue has been under-researched and could have significant impacts on patients who may be at greater risk of heart attacks and strokes. The short answer is – no, in most cases cannabinoids do not seem to act as strong blood thinners.

Blood Pressure 112

Blood Pressure Cannabinoids Patients THC 112

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. But many new patients need an introduction on THC basics, learning how it plays a role in a patient’s well-being and healing.

THC 66

THC Patients Blood Pressure Clinical Trials 66

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. Cannabinoids Many of the components found in Cannabis plants are known as cannabinoids. Cannabinoids will interact with neurological receptors in the human body in the same way that naturally occurring chemicals would.

Epilepsy 100

Epilepsy Pharmaceutical Cannabinoids THC 100

Cannabis Law Report

AUGUST 12, 2022

. – August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

Extraction 52

Extraction Pharmaceutical Patients THC 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Canna Care Docs

NOVEMBER 4, 2024

Doctor is carefully examining a patient’s knee, providing personalized care and support. With a long history, it’s no surprise that patients still use medical cannabis to manage pain holistically. Patients dealing with chronic pain from numerous conditions are finding relief in cannabis. Since 2727 B.C.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 105

Sleep Cannabinoids Patients CBD 105

SpeedWeed

AUGUST 8, 2021

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . If all goes according to plan, patients will receive Sativex and the temozolomide chemotherapy drug, temozolomide on its own, or a placebo. View original article.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64